Edition:
United States

People: Pfizer Inc (PFE)

PFE on New York Consolidated

35.83USD
18 Oct 2017
Change (% chg)

$0.00 (+0.00%)
Prev Close
$35.83
Open
--
Day's High
--
Day's Low
--
Volume
175
Avg. Vol
17,248,319
52-wk High
$36.60
52-wk Low
$29.83

Bourla, Albert 

Mr. Albert Bourla is Group President - Pfizer Innovative Health of the company. He was Group President, Global Innovative Pharma Business from February 2016 until June 2016 and Group President, Vaccines, Oncology and Consumer Healthcare since January 2014. President and General Manager of Established Products Business Unit from December 2010 until December 2013. Area President Europe, Africa, Asia and Pacific of Pfizer Animal Health from 2009 until November 2010. Area President Europe, Africa and Middle East of Pfizer Animal Health from 2005 until 2009.

Basic Compensation

Total Annual Compensation, USD 2,905,500
Restricted Stock Awards, USD 936,941
Long-Term Incentive Plans, USD --
All Other, USD 5,028,000
Fiscal Year Total, USD 8,870,440

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised 20,000 101,074.00
Name Fiscal Year Total

Ian Read

17,321,500

Frank D'Amelio

7,694,350

Albert Bourla

8,870,440

Mikael Dolsten

8,227,970

John Young

7,395,740

Rady Johnson

--
As Of  30 Dec 2016